- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
Experts Offer Roadmap for Treating CLL During the Pandemic -
ASH 2020Early Responders Could Halt Advanced CLL Combo Therapy
-
ASH 2020Fixed Duration Ibrutinib/Venetoclax Feasible for Some CLL/SLL
-
ASH 2020Duvelisib Response Rate 'Exciting' in Patients With r/r PTCL
-
Pigment Traits, Sun Sensitivity Tied to Risk for Blood Cancers
-
Meta-Analysis: Acalabrutinib Bests Other Frontline CLL Therapies
-
Which Drug Therapy for CLL, Time-Limited or Continuous?
-
AlertFDA OKs Ofatumumab (Kesimpta) for Relapsing Forms of MS
Perspective View All
Journal Articles View All
-
Cardio-Oncology: Ibrutinib Effect Reveals Insights Into AF
-
Combination Obinutuzumab, Ibrutinib, and Venetoclax in CLL
-
Acalabrutinib vs Idelalisib-R or Bendamustine-R in CLL
-
Cladribine With Concurrent or Delayed Rituximab in HCL
-
Rapid Cognitive Decline in a Patient With CLL
-
HBV and HCV Infection and Risk of Hematological Malignancies
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education